These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 29029436)
21. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway. Liu L; Lu W; Ma Z; Li Z Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596 [TBL] [Abstract][Full Text] [Related]
22. Basic fibroblast growth factor activates β-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats. Ge Z; Li B; Zhou X; Yang Y; Zhang J Mol Cell Biochem; 2016 Dec; 423(1-2):165-174. PubMed ID: 27734223 [TBL] [Abstract][Full Text] [Related]
23. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β. Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215 [TBL] [Abstract][Full Text] [Related]
24. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice. Xu PB; Mao YF; Meng HB; Tian YP; Deng XM Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985 [TBL] [Abstract][Full Text] [Related]
25. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats. Wang Y; Huang G; Mo B; Wang C Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323108 [TBL] [Abstract][Full Text] [Related]
26. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats. Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887 [TBL] [Abstract][Full Text] [Related]
27. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21. Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671 [TBL] [Abstract][Full Text] [Related]
28. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice. Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100 [TBL] [Abstract][Full Text] [Related]
29. Integrated proteomics and metabolomics reveal variations in pulmonary fibrosis development and the potential therapeutic effect of Shuangshen Pingfei formula. Chen Y; Li X; Fan X J Ethnopharmacol; 2023 Mar; 303():115894. PubMed ID: 36356715 [TBL] [Abstract][Full Text] [Related]
32. Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition. Li LC; Xu L; Hu Y; Cui WJ; Cui WH; Zhou WC; Kan LD Front Pharmacol; 2017; 8():513. PubMed ID: 28848434 [TBL] [Abstract][Full Text] [Related]
33. Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork. Villarreal G; Chatterjee A; Oh SS; Oh DJ; Kang MH; Rhee DJ Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7433-40. PubMed ID: 25352117 [TBL] [Abstract][Full Text] [Related]
34. Preventive Effects of Rhodiola rosea L. on Bleomycin-Induced Pulmonary Fibrosis in Rats. Zhang K; Si XP; Huang J; Han J; Liang X; Xu XB; Wang YT; Li GY; Wang HY; Wang JH Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271612 [TBL] [Abstract][Full Text] [Related]
35. Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes. Hamburg-Shields E; DiNuoscio GJ; Mullin NK; Lafyatis R; Atit RP J Pathol; 2015 Apr; 235(5):686-97. PubMed ID: 25385294 [TBL] [Abstract][Full Text] [Related]
36. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917 [TBL] [Abstract][Full Text] [Related]
37. Depletion of Ianni A; Hofmann M; Kumari P; Tarighi S; Al-Tamari HM; Görgens A; Giebel B; Nolte H; Krüger M; Salwig I; Pullamsetti SS; Günther A; Schneider A; Braun T Front Cell Dev Biol; 2021; 9():639162. PubMed ID: 34124033 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β. Yu SH; Liu LJ; Lv B; Che CL; Fan DP; Wang LF; Zhang YM Cell Biochem Funct; 2015 Aug; 33(6):356-66. PubMed ID: 26178702 [TBL] [Abstract][Full Text] [Related]
39. Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. Della Latta V; Cecchettini A; Del Ry S; Morales MA Pharmacol Res; 2015 Jul; 97():122-30. PubMed ID: 25959210 [TBL] [Abstract][Full Text] [Related]
40. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition. Cui W; Li L; Li D; Mo X; Zhou W; Zhang Z; Xu L; Zhao P; Qi L; Li P; Gao J Inflamm Res; 2015 Dec; 64(12):953-61. PubMed ID: 26411348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]